In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints. Prevention of osteoarthritis progression

American Journal of Pathology

Volumn 154, Issue 4, 1999, Pages 1159-1169

  Fernandes, Julio ^a   Tardif, Ginette ^a   Martel Pelletier, Johanne ^a   Lascau Coman, Viorica ^a   Dupuis, Martine ^a   Moldovan, Florina ^b   Sheppard, Mike ^b   Krishnan, B Rajendra ^b   Pelletier, Jean Pierre ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Box 384   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPID; POLYCLONAL ANTIBODY; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA DETERMINATION; DOSE RESPONSE; FEMUR CONDYLE; GENE THERAPY; HISTOPATHOLOGY; IMMUNOPEROXIDASE STAINING; INJECTION; INTERMETHOD COMPARISON; MENISCECTOMY; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; PLASMID; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME;

EID: 0032924502     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65368-0     Document Type: Article

References (44)

1. Pelletier JP, Martel-Pelletier J, Howell DS: Etiopathogenesis of osteoarthritis. Arthritis and Allied Conditions: A Textbook of Rheumatology. Ed. 13. Edited by WJ Koopman. Baltimore, Williams & Wilkins, 1997, pp 1969-1984
2. Pelletier JP, Di Battista JA, Roughley PJ, McCollum R, Martel-Pelletier J: Cytokines and inflammation in cartilage degradation. Osteoarthritis. Edition of Rheumatic Disease Clinics of North America. Edited by RW Moskowitz. Philadelphia, W.B. Saunders Company, 1993, pp 545-568
3. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J: Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 1995, 22:109-114
4. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaifler NJ: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 1992, 149:1054-1062
5. Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J: The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 1996, 4:77-84
6. Sadouk M, Pelletier JP, Tardif G, Kiansa K, Cloutier JM, Martel-Pelletier J: Human synovial fibroblasts coexpress interleukin-1 receptor type I and type II mRNA: the increased level of the interleukin-1 receptor in osteoarthritic cells is related to an increased level of the type 1 receptor. Lab Invest 1995, 73:347-355
7. Martel-Pelletier J, McCollum R, Di Battista JA, Faure MP, Chin JA, Fournier S, Sarfati M, Pelletier JP: The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 1992, 35:530-540
8. Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995, 38:151-160
9. Arner EC, Harris RR, DiMeo TM, Collins RC, Galbraith W: Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit. J Rheumatol 1995, 22:1338-1346
10. Arend WP: Interleukin-1 receptor antagonist [review]. Adv Immunol 1993, 54:167-227
11. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier JP: Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 1996, 39: 1535-1544
12. Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH: Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 1993, 90:10764-10768
13. Baragi VM, Renkiewicz RR, Jordan H, Bonadio J, Harman JW, Roessler BJ: Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest 1995, 96:2454-2460
14. Pelletier JP, Caron JP, Evans CH, Robbins PD, Georgescu HI, Jovanovic D, Fernandes JC, Martel-Pelletier J: In vivo suppression of early experimental osteoarthritis by IL-Ra using gene therapy. Arthritis Rheum 1997, 40:1012-1019
15. Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos K, Gould D, Dreja H, Moyes SP, Croxford JL, Mageed RA, Podhajcer OL, Baker D: Gene therapy for rheumatoid arthritis. Theoretical considerations. Drugs Aging 1998, 12:29-41
16. Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano M: Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group. Arthritis Rheum 1996, 39:1092-1101
17. Evans CH, Robbins PD: Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumaol 1996, 8:230-234
18. Moskowitz RW, Davis W, Sammarco J, Martens M, Baker J, Mayor M, Burstein AH, Frankel VH: Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum 1973, 16:397-405
19. Moskowitz RW: Experimental models of osteoarthritis. Osteoarthritis. Diagnosis and Medical/Surgical Management. Ed. 2. Edited by RW Moskowitz, DS Howell, VM Goldberg, HJ Mankin. Philadelphia, W.B. Saunders Company, 1992, pp 213-232
20. Moskowitz RW, Goldberg VM: Studies of osteophyte pathogenesis in experimentally induced osteoarthritis. J Rheumatol 1987, 14:311-320
21. Pelletier JP, Mineau F, Raynauld JP, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J: Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994, 37:414-423
22. Mankin HJ, Dorfman H, Lippiello L, Zarins A: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971, 53:523-537
23. Pelletier JP, Martel-Pelletier J, Ghandur-Mnaymneh L, Howell DS, Woessner JF Jr: Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1985, 28:554-561
24. Moldovan F, Pelletier JP, Hambor J, Cloutier JM, Martel-Pelletier J: Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor β. Arthritis Rheum 1997, 40: 1653-1661
25. Pelletier JP, Faure MP, Di Battista JA, Wilhelm S, Visco D, Martel-Pelletier J: Coordinate synthesis of stromelysin, interleukin-1, and oncogens proteins in experimental osteoarthritis: an immunohistochemical study. Am J Pathol 1993, 142:95-105
26. Parker SE, Khatibi S, Margalith M, Anderson D, Yankauckas M, Gromkowski SH, Latimer T, Lew D, Marquet M, Manthorpe M, Hobart P, Hersh E, Stopeck AT, Norman J: Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo. Cancer Gene Ther 1996, 3:175-185
27. Eisenberg SP, Evares RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression of complimentary DNA of a human interleukin-1 receptor antagonist Nature 1990, 343:341-346
28. Evans CH, Robbins PD: Gene therapy for arthritis. Gene Therapeutics: Methods and Applications of Direct Gene Transfer Edited by JA Wolff. Boston, Birkhauser, 1994, pp 320-343
29. Evans C, Robbins PD: Prospects for treating arthritis by gene therapy [editorial]. J Rheumatol 1994, 21:779-782
30. Bandara G, Robbins PD, Georgescu HI, Mueller GM, Glorioso JC, Evans CH: Gene transfer to synoviocytes: prospects for gene treatment for arthritis. DNA Cell Biol 1992, 11:227-231
31. Otani K, Nita IM, Macaulay W, Georgescu HI, Robbins PD, Evans CH: Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 1996, 156:3558-3562
32. Makarov SS, Olsen JC, Johnston WN, Schwab JH, Anderle SK, Brown RR, Haskill JS: Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats. Gene Ther 1995, 2: 424-428
33. Hung GL, Galea-Lauri J, Mueller GM, Georgescu HI, Larkin LA, Suchanek MK, Tindal MH, Robbins PD, Evans CH: Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1994, 1:64-69
34. Roessler BJ, Allen ED, Wilson JM, Hartman JW, Davidson BL: Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 1993, 92:1085-1092
35. Nita IM, Ghivizzani SC, Galea-Lauri J, Bandara G, Georgescu HI, Robbins PD, Evans CH: Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 1996, 39:820-828
36. Tomita N, Morishita R, Higaki J, Tomita S, Aoki M, Ogihara T, Kaneda Y: In vivo gene transfer to insulin gene into neonatal rats by the HVJ-liposome method resulted in sustained transgene expression. Gene Ther 1996, 3:477-482
37. Tomita T, Hashimoto H, Tomita N, Morishita R, Lee SB, Hayashida K, Nakamura N, Yonenobu K, Kaneda Y, Ochi T: In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (sendai virus) and liposomes. Arthritis Rheum 1997, 40(5): 901-906
38. Yovandich J, O'Malley B, Sikes M, Ledley FD: Gene transfer to synovial cells by intra-articular administration of plasmid DNA. Hum Gene Ther 1995, 6:603-610
39. Budker V, Zhang G, Danko I, Williams P, Wolff J: The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther 1998, 5:272-276
40. Hartikka I, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing HL, Meek J, Marquet M, Hobart P, Norman J, Manthorpe M: An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 1996, 7:1205-1217
41. Stephan DJ, Yang ZY, San H, Simari RD, Wheeler CJ, Felgner PL, Gordon D, Nabel GJ, Nabel EG: A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996, 7:1803-1812
42. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirum vectors. Nat Med 1996, 2:545-550
43. Glansbeek HL, Van Beuningen HM, Vitters EL, Van der Kraan PM, van den Berg WB: Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-β into murine knee joints. Lab Invest 1998, 78:133-142
44. Palmer TD, Rosman GJ, Osborne WR, Miller AD: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 1996, 88:1330-1334